Anthony Vecchione
The collaboration aims to foster innovation, commercialization and adoption of AI in imaging.
DarioHealth, Clover Health and eHealth also released third-quarter financial results.
HATCo will spend a total of $550 million in capital funding to invest in technologies and innovation.
The behavioral health company's Engage platform will be available to existing commercial fully insured, self-funded members on an opt-in basis and via Sentara's Marketplace membership.
The aim of the alliance is to collect insights on patient outcomes and drug effectiveness with the Dario Connect platform.
The funding will support clinical trials for the company's NeuroHawk brain-scanning device.
The acquisition includes Jack's Canadian clinical assets, the authority to operate 16 medical clinics across 13 Canadian cities and the rights to operate clinics in Walmart stores in Canada.
The aim is to attract government and healthcare experts who can gain a better understanding of digitalization in healthcare.
MedAware's AI-enabled platform allows pharmacists and clinical care personnel to intervene with medication dosages and therapy changes before potential harm occurs.
The funds will be used to scale partnerships with health plans, employers and community-based public health agencies across the country.